Until 2018, genetic counselling and testing at the Amsterdam UMC PH centre was not routinely offered to sporadic PAH patients and was restricted to the sequencing of BMPR2 and SMAD9 genes. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.